Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer.

Authors:
Gao M; Wu X; Jiao X; Hu Y; Wang Y and 10 more

Journal:
J Immunother Cancer

Publication Year: 2024

DOI:
10.1136/jitc-2022-006616

PMCID:
PMC10836376

PMID:
38302415

Journal Information

Full Title: J Immunother Cancer

Abbreviation: J Immunother Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the final assay readout is presented in normalized protein expression values which is an arbitrary unit on a log2-scale where a higher value corresponds to a higher protein expression 10 1136/jitc-2022-006616 supp1 supplementary data 10 1136/jitc-2022-006616 supp2 supplementary data measurements were performed using 1 ul of each sample.; specially we found that cd5 and il-15 were elevated after treatment only in responders while 30 plasma proteins were detected to be altered in nrs ( online supplemental figure s2 ) 10 1136/jitc-2022-006616 supp4 supplementary data 10 1136/jitc-2022-006616 supp5 supplementary data to explore the utility of plasma for ici prediction we analyzed the association between pretreatment plasma protein levels and survival outcomes.; our results support the application of plasma proteome sequencing and provide a clinical implication for combinations of icis with antiangiogenic therapy in the future 10 1136/jitc-2022-006616 supp3 supplementary data 10 1136/jitc-2022-006616 supp7 supplementary data we thank the patients and their families for their contribution to this study."

Code Sharing
Evidence found in paper:

"Competing interests: None declared."

Evidence found in paper:

"Funding: This work was supported by the National Key Research and Development Program of China (2020YFE0202200), the State Key Program of National Natural Science Foundation of China (grant 92159106), the National Youth Top-Level Talent Support Program of Chain (12Y4962)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025